Evrysdi Leads to Longer-term Benefits for SMA Types 2, 3, Data Show episode artwork

EPISODE · Mar 31, 2021 · 11 MIN

Evrysdi Leads to Longer-term Benefits for SMA Types 2, 3, Data Show

from The Spinal Muscular Atrophy Podcast with Kevin Schaefer · host SMA News Today

SMA News Today’s multimedia associate, Price Wooldridge, discusses how Evrysdi leads to longer-term benefits for Spinal Muscular Atrophy (SMA) patients, Types 2 and 3.Forums Director Kevin Schaefer talks about disability representation in the movie “Zack Snyder’s Justice League.”Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/

Episode metadata supplied by the publisher feed · Published Mar 31, 2021

Embed this episode

Ready to play

Evrysdi Leads to Longer-term Benefits for SMA Types 2, 3, Data Show

0:00 11:35

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Spinal Muscular Atrophy Podcast with Kevin Schaefer?

This episode is 11 minutes long.

When was this The Spinal Muscular Atrophy Podcast with Kevin Schaefer episode published?

This episode was published on March 31, 2021.

Can I download this The Spinal Muscular Atrophy Podcast with Kevin Schaefer episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!